MOFs‐Based Magnetic Nanozyme to Boost Cascade ROS Accumulation for Augmented Tumor Ferroptosis
Advanced Healthcare Materials · 2024-08 · 13 (20)
DOI: 10.1002/adhm.202304591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 30.04.2024. Verfasst von Ying Yuan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Materials Science and Devices, School of Materials Science and Engineering, Suzhou University of Science and Technology, Suzhou, Jiangsu…. Hauptthemen laut MEDLINE: Ferroptosis, Metal-Organic Frameworks, Reactive Oxygen Species. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
The emerging cell death modality of ferroptosis has garnered increasing attention for antitumor treatment but still suffers from low therapeutic efficacy. A metal–organic frameworks (MOFs)‐based magnetic nanozyme (PZFH) comprising porphyrin‐based Zr‐MOF (PCN) on zinc ferrite (ZF) nanoparticles modified with hyaluronic acid, delivering excellent magnetophotonic response for efficient ferroptosis, is reported here. PZFH shows multienzyme‐like cascade activity encompassing a photon‐triggered oxidase‐like catalysis to generate O 2 − , which is converted to H 2 O 2 by superoxide dismutase‐like activity and subsequent ·OH by magneto‐promoted peroxidase (POD) behavior. Newly formed Fe─N coordination and increased Fe 2+ /Fe 3+ levels in the PZFH contribute to the enhanced POD activity, which is further enhanced by accelerated surface electron transfer when exposure to alternated magnetic field. Accumulation of lipid peroxides is eventually accomplished through the conversion of ·OH radicals and singlet oxygen ( 1 O 2 ) produced through laser irradiation. When combined with the depletion of inhibition of glutathione and glutathione peroxidase 4, PZFH exhibits significantly enhanced ferroptosis in tumor‐bearing mice, offering insights into nanomedicine for ferroptosis and holding great promise in clinical antitumor therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Materials Science and Devices, School of Materials Science and Engineering, Suzhou University of Science and Technology, Suzhou, Jiangsu, 215009, P. R. China.
- State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Sciences and Medical Engineering, Southeast University, Nanjing, 210096, P. R. China.
- The Third School of Clinical Medical, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, P. R. China.
- Department of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.
ORCID-Profile: Chang Ming Li
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Yuan, Y., Chen, B., An, X., Guo, Z., Liu, X., Lu, H., Hu, F., Chen, Z., Guo, C., & Li, C. M. (2024). MOFs‐Based Magnetic Nanozyme to Boost Cascade ROS Accumulation for Augmented Tumor Ferroptosis. Advanced Healthcare Materials, 13(20). https://doi.org/10.1002/adhm.202304591
Vancouver
Yuan Y, Chen B, An X, Guo Z, Liu X, Lu H, et al. MOFs‐Based Magnetic Nanozyme to Boost Cascade ROS Accumulation for Augmented Tumor Ferroptosis. Advanced Healthcare Materials. 2024;13(20). doi:10.1002/adhm.202304591
BibTeX
@article{Yuan2024,
author = {Yuan, Ying and Chen, Bo and An, Xingxing and Guo, Zhanhang and Liu, Xin and Lu, Hao and Hu, Fangxin and Chen, Zhigang and Guo, Chunxian and Li, Chang Ming},
title = {MOFs‐Based Magnetic Nanozyme to Boost Cascade ROS Accumulation for Augmented Tumor Ferroptosis},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {20},
doi = {10.1002/adhm.202304591}
}
EUVIMED